Lipella Pharmaceuticals Inc. (LIPO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$3.16M
Year ended 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$3.16Mn/a2025-03-28, From 2023-01-01